Wuxi Biologics Stock Today

WXXWY Stock  USD 7.17  0.24  3.46%   

Performance

Solid

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
WuXi Biologics is trading at 7.17 as of the 19th of March 2025; that is 3.46 percent increase since the beginning of the trading day. The stock's open price was 6.93. WuXi Biologics has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
WuXi Biologics Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the Peoples Republic of China, North America, Europe, and internationally. The company was incorporated in 2014 and is headquartered in Wuxi, China. The company has 2.11 B outstanding shares. More on WuXi Biologics

Moving together with WuXi Pink Sheet

  0.81VRTX Vertex PharmaceuticalsPairCorr

Moving against WuXi Pink Sheet

  0.88CSLLY CSLPairCorr
  0.68QMCO Quantum TrendingPairCorr
  0.64CMXHF CSL LimitedPairCorr
  0.64KB KB Financial GroupPairCorr
  0.55SHG Shinhan FinancialPairCorr
  0.53CHNXF ChitogenXPairCorr

WuXi Pink Sheet Highlights

CEO, Executive DirectorZhisheng Chen
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
WuXi Biologics [WXXWY] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 34.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate WuXi Biologics's market, we take the total number of its shares issued and multiply it by WuXi Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. WuXi Biologics classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 2.11 B outstanding shares. WuXi Biologics has accumulated about 9.86 B in cash with 3.43 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.72.
Check WuXi Biologics Probability Of Bankruptcy
Ownership Allocation
WuXi Biologics retains a total of 2.11 Billion outstanding shares. Roughly 99.99 (%) of WuXi Biologics outstanding shares are held by general public with 0.007 percent by institutional investors. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check WuXi Ownership Details

WuXi Biologics Risk Profiles

WuXi Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in WuXi Biologics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Economic Indicators Now

   

Economic Indicators

Top statistical indicators that provide insights into how an economy is performing
All  Next Launch Module

WuXi Biologics Corporate Management

Additional Tools for WuXi Pink Sheet Analysis

When running WuXi Biologics' price analysis, check to measure WuXi Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WuXi Biologics is operating at the current time. Most of WuXi Biologics' value examination focuses on studying past and present price action to predict the probability of WuXi Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WuXi Biologics' price. Additionally, you may evaluate how the addition of WuXi Biologics to your portfolios can decrease your overall portfolio volatility.